High-risk HPV nucleic acid detection kit-the careHPV test -a new detection method for screening

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Ying, Hong ^a   Jing, Fang ^a   Fanghui, Zhao ^b   Youlin, Qiao ^b   Yali, Hu ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC KIT; VIRUS DNA;

ADULT; AREA UNDER THE CURVE; DIAGNOSTIC KIT; EVALUATION STUDY; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; UTERINE CERVIX; VIROLOGY;

ADULT; AREA UNDER CURVE; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; ROC CURVE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 84898684089     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04704     Document Type: Article

References (15)

1. Boyle, P. & Ferlay, J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 16, 481-8 (2005).
2. IARC. World Health Organization. IARC handbooks of cancer prevention: cervix cancer screening. Lyon, France, IARC. 10, 239-41 (2005).
3. Tsu, V. D. & Pollack, A. E. Preventing cervical cancer in low-resource settings: how far have we come and what does the future hold? Int J Gynaecol Obstet. 89 Suppl 2:S55-9 (2005).
4. De Francesco, M. A. et al. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J Med Virol. 75, 588-92 (2005).
5. Cuzick, J. et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 26 Suppl 10:K29-41 (2008).
6. Cuzick, J. et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 119, 1095-101 (2006).
7. Gravitt, P. E. et al. New technologies in cervical cancer screening. Vaccine. 26 Suppl 10:K42-52 (2008).
8. Denny, L. et al. Screen-and-treat approaches for cervical cancer prevention in lowresource settings: a randomized controlled trial. JAMA. 294, 2173-81 (2005).
9. Sherris, J. et al. Alliance for cervical cancer prevention: setting the record straight. Am J Public Health. 97, 200-1 (2007).
10. Hu, S. Y. et al. Prevalence of HPV Infection And Cervical Intraepithelial Neoplasia And Attitudes towards HPV Vaccination among Chinese Women Aged 18-25 in Jiangsu Province. Chin J Cancer Res. 23, 25-32 (2011).
11. Bulkmans, N. W. et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 370, 1764-72 (2007).
12. Qiao, Y. L. et al. Anew HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 9, 929-36 (2008).
13. Levin, C. E. et al. Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China. Int J Cancer. 127, 1404-11 (2010).
14. Goldie, S. J. et al. Alliance for Cervical Cancer Prevention Cost Working Group. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 353, 2158-68 (2005).
15. Hong, Y., Li, S. Q., Hu, Y. L. &Wang, Z. Q. Survey of human papillomavirus types and their vertical transmission in pregnant women. BMC Infect Dis. 27(13), 109 (2013).